Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 30 studies | 39% ± 16% | |
| macrophage | 22 studies | 42% ± 23% | |
| dendritic cell | 18 studies | 51% ± 24% | |
| conventional dendritic cell | 16 studies | 35% ± 15% | |
| plasmacytoid dendritic cell | 16 studies | 35% ± 11% | |
| astrocyte | 16 studies | 37% ± 16% | |
| microglial cell | 16 studies | 59% ± 20% | |
| monocyte | 14 studies | 38% ± 23% | |
| B cell | 13 studies | 29% ± 14% | |
| classical monocyte | 13 studies | 27% ± 10% | |
| smooth muscle cell | 13 studies | 37% ± 15% | |
| ciliated cell | 12 studies | 36% ± 14% | |
| oligodendrocyte precursor cell | 12 studies | 38% ± 18% | |
| pericyte | 12 studies | 32% ± 13% | |
| myeloid cell | 11 studies | 45% ± 20% | |
| fibroblast | 11 studies | 36% ± 11% | |
| mast cell | 11 studies | 38% ± 16% | |
| basal cell | 10 studies | 38% ± 21% | |
| non-classical monocyte | 9 studies | 27% ± 12% | |
| adipocyte | 9 studies | 27% ± 7% | |
| endothelial cell of lymphatic vessel | 9 studies | 38% ± 13% | |
| club cell | 8 studies | 37% ± 19% | |
| GABAergic neuron | 8 studies | 37% ± 15% | |
| glutamatergic neuron | 8 studies | 39% ± 21% | |
| epithelial cell | 7 studies | 42% ± 25% | |
| vein endothelial cell | 7 studies | 31% ± 18% | |
| respiratory goblet cell | 6 studies | 49% ± 23% | |
| hematopoietic precursor cell | 5 studies | 52% ± 21% | |
| CD4-positive, alpha-beta T cell | 5 studies | 24% ± 6% | |
| neuron | 5 studies | 34% ± 17% | |
| interneuron | 5 studies | 40% ± 22% | |
| plasma cell | 5 studies | 43% ± 15% | |
| cardiac muscle cell | 5 studies | 28% ± 7% | |
| T cell | 5 studies | 29% ± 7% | |
| hematopoietic stem cell | 5 studies | 43% ± 17% | |
| type I pneumocyte | 5 studies | 26% ± 6% | |
| type II pneumocyte | 5 studies | 33% ± 7% | |
| squamous epithelial cell | 4 studies | 32% ± 23% | |
| endothelial cell of artery | 4 studies | 24% ± 8% | |
| mononuclear phagocyte | 4 studies | 39% ± 16% | |
| endothelial cell of vascular tree | 4 studies | 41% ± 15% | |
| capillary endothelial cell | 4 studies | 35% ± 13% | |
| leukocyte | 4 studies | 51% ± 17% | |
| oligodendrocyte | 4 studies | 28% ± 11% | |
| secretory cell | 3 studies | 33% ± 9% | |
| endothelial cell of sinusoid | 3 studies | 26% ± 12% | |
| plasmablast | 3 studies | 32% ± 6% | |
| GABAergic interneuron | 3 studies | 20% ± 3% | |
| glial cell | 3 studies | 19% ± 4% | |
| myofibroblast cell | 3 studies | 44% ± 15% | |
| Mueller cell | 3 studies | 21% ± 5% | |
| cholangiocyte | 3 studies | 54% ± 18% | |
| hepatocyte | 3 studies | 52% ± 28% | |
| connective tissue cell | 3 studies | 27% ± 7% | |
| ependymal cell | 3 studies | 37% ± 15% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 68% ± 4% | |
| neutrophil | 3 studies | 36% ± 14% | |
| alveolar macrophage | 3 studies | 69% ± 11% | |
| natural killer cell | 3 studies | 24% ± 2% | |
| memory B cell | 3 studies | 17% ± 2% | |
| lymphocyte | 3 studies | 36% ± 4% | |
| goblet cell | 3 studies | 48% ± 30% | |
| mesothelial cell | 3 studies | 24% ± 10% | |
| mural cell | 3 studies | 41% ± 8% | |
| mucus secreting cell | 3 studies | 62% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 3989.62 | 21 / 21 | 100% | 31.27 | 504 / 504 |
| breast | 100% | 5936.26 | 459 / 459 | 100% | 46.58 | 1118 / 1118 |
| esophagus | 100% | 2950.91 | 1445 / 1445 | 100% | 37.87 | 183 / 183 |
| intestine | 100% | 4067.42 | 966 / 966 | 100% | 28.95 | 527 / 527 |
| prostate | 100% | 4143.09 | 245 / 245 | 100% | 19.59 | 502 / 502 |
| lung | 100% | 4434.78 | 578 / 578 | 100% | 32.78 | 1152 / 1155 |
| thymus | 100% | 2759.74 | 652 / 653 | 100% | 23.75 | 604 / 605 |
| uterus | 100% | 2294.44 | 170 / 170 | 100% | 28.76 | 457 / 459 |
| skin | 100% | 4649.58 | 1808 / 1809 | 99% | 24.91 | 468 / 472 |
| kidney | 100% | 2237.72 | 89 / 89 | 98% | 19.60 | 887 / 901 |
| stomach | 97% | 1923.03 | 347 / 359 | 100% | 31.40 | 286 / 286 |
| pancreas | 97% | 1591.48 | 317 / 328 | 99% | 31.55 | 176 / 178 |
| ovary | 91% | 1307.03 | 164 / 180 | 100% | 34.64 | 430 / 430 |
| adrenal gland | 100% | 2423.71 | 258 / 258 | 78% | 9.11 | 179 / 230 |
| liver | 88% | 1328.45 | 199 / 226 | 75% | 8.72 | 303 / 406 |
| brain | 37% | 411.90 | 977 / 2642 | 99% | 14.34 | 696 / 705 |
| blood vessel | 100% | 6088.89 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4946.11 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 43.47 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 16.47 | 1 / 1 |
| adipose | 100% | 4026.79 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 5209.29 | 923 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 27.79 | 28 / 29 |
| eye | 0% | 0 | 0 / 0 | 91% | 9.93 | 73 / 80 |
| heart | 84% | 1074.42 | 724 / 861 | 0% | 0 | 0 / 0 |
| muscle | 58% | 733.14 | 463 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0097152 | Biological process | mesenchymal cell apoptotic process |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0071425 | Biological process | hematopoietic stem cell proliferation |
| GO_0022008 | Biological process | neurogenesis |
| GO_0030154 | Biological process | cell differentiation |
| GO_0007296 | Biological process | vitellogenesis |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0019904 | Molecular function | protein domain specific binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ETV6 |
| Protein name | ETV6 protein (TEL) Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel) ETS variant transcription factor 6 Ets variant 6 isoform 1 Ets variant 6 isoform 2 ETV6 protein |
| Synonyms | TEL1 TEL |
| Description | FUNCTION: Transcriptional repressor; binds to the DNA sequence 5'-CCGGAAGT-3'. Plays a role in hematopoiesis and malignant transformation. . |
| Accessions | P41212 ENST00000545027.1 Q9UME7 H0YG25 ENST00000266427.3 Q1XE77 A0A0S2Z3N6 Q9UBM2 J3KN52 A0A0S2Z3C9 ENST00000396373.9 |